3Leli C, Mencacei A, Bombaci JC, et al. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients[J]. Infez Med,2012,20(2):82-87.
5Biernat - Sudolska M, Szostek S, Rojek - Zakrzewska D, et al. Con- comitant infections with human papillomavirus and various mycoplasma and ureaplasma species in women with abnormal cervical cytology [ J ]. Adv Med Sci, 2011,56(2) :299 -303.
6McGowin CL, Popov VL, Pyles RB. Intracellular Mycoplasma geni - talium infection of human vaginal and cervical epithelial cellselicits dis- tinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage- mediated killing[ J]. BMC Mierobiol, 2009,9:139.
7Mallard K, Schopfer K, Bodmer T. Development of real -time PCR for the diferential detection and quantification of Ureaplasma urealyticum and Ure- aplasma parvum. [ J]. J Microbiol Methods, 2005,60(1) :13-19.
8Xiao L, Crabb DM, Duffy LB, et al. Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp [ J ]. Int J Antimicrob Agents, 2011,37 (4) :377 - 379.
9Xiao L, Crabb DM, Duffy LB, et al. Chromosomal mutations responsi- ble for fluoroquinolone resistance in Ureaplasma species in the United States[ J]. Antimierob Agents Chemother, 2012,56 (5) :2780 - 2783.
10Bharat A,Cunningham SA, Scott Budinger GR, et al. Dis- seminated Ureaplasma infection as a cause of fatal hy- perammonemia in humans [J]. Sei Transl Med, 2015, 7 (284) : 284re3.
